These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7430018)
1. Prolonged bleeding time during azlocillin therapy. Dijkmans BA; Van Der Meer JW; Boekhout-Mussert MJ; Zaal-De Jong M; Mattie H J Antimicrob Chemother; 1980 Jul; 6(4):554-6. PubMed ID: 7430018 [No Abstract] [Full Text] [Related]
2. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa. Vestin L; Burman LA; Holm S; Sellers J Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781 [TBL] [Abstract][Full Text] [Related]
3. Azlocillin sodium (AZLIN). Med Lett Drugs Ther; 1982 Dec; 24(625):113-4. PubMed ID: 7144692 [No Abstract] [Full Text] [Related]
4. Comparative clinical evaluation of azlocillin and gentamicin. Sabbaj J; Torres M; Loza L J Antimicrob Chemother; 1983 May; 11 Suppl B():175-81. PubMed ID: 6619027 [TBL] [Abstract][Full Text] [Related]
5. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections]. Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607 [TBL] [Abstract][Full Text] [Related]
7. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis. Michalsen H; Bergan T Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708 [TBL] [Abstract][Full Text] [Related]
8. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa. Gonzalez MA J Antimicrob Chemother; 1983 May; 11 Suppl B():169-74. PubMed ID: 6352600 [TBL] [Abstract][Full Text] [Related]
9. The use of azlocillin to treat serious infections. Neu HC; Francke EL; Ortiz-Neu C; Prince AS J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023 [TBL] [Abstract][Full Text] [Related]
13. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic. Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections. del Rosal PL J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers]. Konopka CA Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600 [TBL] [Abstract][Full Text] [Related]
16. [Comparative antibacterial effect of azlocillin, ticarcillin and carbenicillin on pseudomonas bacteria]. Jotzoff M Med Welt; 1981 Sep; 32(39):1448-9. PubMed ID: 7300647 [No Abstract] [Full Text] [Related]
18. [Role of azlocillin in the treatment of Pseudomonas urinary infections]. Canton P Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin. Leung AC; Gribben J; Sleigh JD; Boulton Jones JM Scott Med J; 1983 Jan; 28(1):69-70. PubMed ID: 6403983 [No Abstract] [Full Text] [Related] [Next] [New Search]